 |
Joern B. Soltau, M.D."A physician's job is more than just solving a particular vision problem. He must also listen to his patients, care for them, understand their needs and see to their comfort." To Schedule an Appointment with Dr. Soltau, Call 502-852-5466 |
Glaucoma is a disease caused by an increase of fluid pressure within the eye. Left untreated, it can result in vision loss. Dr. Soltau specializes in glaucoma treatment and cases of ocular hypertension. As well as seeing patients at the Kentucky Lions Eye Center, he also publishes scientific articles and conducts research grants for the National Institute of Health and various pharmaceutical companies.
Current Position
Assistant Professor, Department of Ophthalmology & Visual Sciences Director, Glaucoma Service Director, Residency Training Program On Staff since 1998
Specialties
Glaucoma, Cataract
Board Certification
American Board of Ophthalmology 1998
Medical License
State of Kentucky
State of Missouri
Germany
Contact Information
jbsolt01@louisville.edu
University of Louisville
Dept. Of Ophthalmology & Visual Science
301 E. Muhammad Ali Blvd.
Louisville, KY 40202
(502) 852-5466
FAX - (502) 852-4947
Education
Ruprecht-Karls-University, Heidelberg, Germany, M.D. 1988
Klinikum Mannheim, Germany - Arzt im Prakitum - Internship, 1989-1990
Department of Ophthalmology & Visual Sciences, University of Louisville - Research Associate, 1990-1992
Department of Internal Medicine, Jewish Hospital of St. Louis - Internship 1992-1993
Department of Ophthalmology & Visual Sciences, Washington University School of Medicine - Residency, 1993-1996
Department of Ophthalmology & Visual Sciences, Washington University School of Medicine - Chief Resident and Director, Barnes-Jewish Eye Clinic and University Eye Service, 1996-1997
Bascom Palmer Eye Institute - Glaucoma Fellow, 1997-1998
Professional Societies and Affiliations
American Academy of Ophthalmology, American Glaucoma Society, Deutsche Ophthalmologische Gesellschaft, Association for Research in Vision and Ophthalmology, Pan-American Association of Ophthalmology, Kentucky Association of Eye Physicians and Surgeons, Louisville Academy of Ophthalmology, Jefferson County Medical Society, and the American Medical Association.
Current Research Grants
National Institute of Health, $180,000 annually Co-Investigator 7/1998 - 12/1999, Principal Investigator 1/2000 - Present "Ocular Hypertension Treatment Study"
Pharmacia Corporation 1999-2004 Principal Investigator, "5 Year Post Market Safety Study of Xalatan
Select Publications
Mac, I., Soltau, J.B.: Glaucoma filtering bleb infections. Curr. Opin. Ophthalmol. 14 (2), 91-94, 2003
Soltau, J.B., Zimmerman, T.J.: Changing paradigms in the medical treatment of glaucoma. Surv. Ophthalmol. 47:S2-S5, 2002.
Kass, M.A., Heuer, D.K., Higginbotham, E.J., et al.: The Ocular Hypertension Treatment Study. A randomized trial determines that topical ocular hypertensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120:701-713, 2002